University of Abuja Teaching Hospital
9
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia.
Role: collaborator
Hypertension Treatment in Nigeria 2.0
Role: collaborator
Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
Role: collaborator
Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health
Role: collaborator
Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program
Role: collaborator
Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design
Role: collaborator
Preventing the Rise in Blood Pressure With Age Using Reduced-sodium Salt
Role: collaborator
Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality
Role: collaborator
Children's Surgery in Sub-Saharan Africa
Role: collaborator
All 9 trials loaded